Is DexCom (DXCM) Undervalued Following Its Investor Day Sentiment Shift?

DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...

Investors’ Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured

Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...
sharewise

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Sports Illustrated

Mark Andrews Discusses 'Elevating Student-Athletes' Through his NIL Partnership

Mark Andrews may be one of the best tight ends in the NFL, but he has not forgotten about the kids playing college football today. The former Oklahoma Sooners standout is using his platform as an ...

Best Smartwatch for Blood Sugar Tracking: Apple Watch, Galaxy Watch, or Pixel Watch?

Compare the Apple Watch, Samsung Galaxy Watch, and Pixel Watch for blood sugar tracking, CGM alerts, health trends, battery ...

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 diabetes using insulin therapy, as well as certain non-insulin users who ...

DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans

DexCom DXCM recently announced that it will begin rolling out its fully reimagined Stelo app experience in the United States starting in July. The updated app, available for Apple iPhone and Android ...

FDA clears Dexcom’s Stelo as first OTC glucose monitor for children

The FDA’s indication expansion for Dexcom’s Stelo makes it the first over the counter CGM available for children, including those with diabetes.

2 Growth Stocks to Buy and Hold for a Decade

Meanwhile, the company is working on newer, better products while also expanding its reach by entering new regions. Dexcom expects 10% organic revenue growth per year through 2030, and it could ...
Insider Monkey

Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery

Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund lost 7.14% in the quarter, tied to ...

DexCom Inc. stock outperforms competitors on strong trading day

Shares of DexCom Inc. DXCM advanced 2.66% to $74.96 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.42% to 7,575.39 and ...
Insider Monkey

DexCom (DXCM) Reports Q1 2026 Revenue of $1.19B with 15% Growth

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to invest in for the next 2 years. On April 30, DexCom reported Q1 2026 revenue of $1.192 billion, representing a 15% year-over-year increase ...